Phase II study of S-1, a novel oral fluoropyrimidine, and biweekly administration of docetaxel for previously treated advanced non-small-cell lung cancer
about
Phase I/II trial of a biweekly combination of S-1 plus docetaxel in patients with previously treated non-small cell lung cancer (KRSG-0601).S-1 combined with docetaxel following doxorubicin plus cyclophosphamide as neoadjuvant therapy in breast cancer: phase II trial.Docetaxel/S-1 Versus Docetaxel/Capecitabine as First-Line Treatment for Advanced Breast Cancer: A Retrospective Study.Efficacy of S-1 in non-small cell lung cancer.
P2860
Phase II study of S-1, a novel oral fluoropyrimidine, and biweekly administration of docetaxel for previously treated advanced non-small-cell lung cancer
description
2010 nî lūn-bûn
@nan
2010 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Phase II study of S-1, a novel ...... ced non-small-cell lung cancer
@ast
Phase II study of S-1, a novel ...... ced non-small-cell lung cancer
@en
type
label
Phase II study of S-1, a novel ...... ced non-small-cell lung cancer
@ast
Phase II study of S-1, a novel ...... ced non-small-cell lung cancer
@en
prefLabel
Phase II study of S-1, a novel ...... ced non-small-cell lung cancer
@ast
Phase II study of S-1, a novel ...... ced non-small-cell lung cancer
@en
P2093
P2860
P1476
Phase II study of S-1, a novel ...... ced non-small-cell lung cancer
@en
P2093
Kentaro Okuda
Masanao Nakashima
Mitsuru Adachi
Sojiro Kusumoto
Takao Shirai
Takashi Hirose
Tohru Ohmori
Tomohide Sugiyama
Toshimitsu Yamaoka
Yasunari Oki
P2860
P2888
P304
P356
10.1007/S00280-010-1382-1
P577
2010-06-17T00:00:00Z
P5875
P6179
1037687711